Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis

Abstract

[Erratum to: BMB Reports 2023; 56(3): 184-189, PMID: 36617466, PMCID: PMC10068343] The BMB Reports would like to correct in BMB Rep. 56(3): 184-189, titled "circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis". This research has the wrong affiliation of the authors and number of affiliation. Since author's affiliation is incorrect, this information has now been corrected as follows. Kaiyun Qin1,3,#, Fenghua Zhang2,#, Hongxia Wang1, Na Wang1, Hongbing Qiu4, Xinzhuan Jia1,5, Shan Gong1 & Zhengmao Zhang1,*1Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, 2Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, 3Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, 4Department of Gynecology, Hebei Xingtai People's Hospital, Hebei Shijiazhuang 054001, 5Department of Reproductive Medicine, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011, China The author apologizes for any inconvenience or confusion this error may cause. Author information has been modified in the original PDF version.